首页> 外国专利> New acetoxy-tetrahydroxy-7-methoxy-2-methyl-tetrahydroanthracen-9,10-dione and 8-(trihydroxy-7-methyl-2-methoxy-9,10-dioxo-anthracen-1-yl)-pentahydroxy-7-methoxy-2-methyl-tetrahydro-anthracen-9,10-dione, useful e.g. as antitumor agents

New acetoxy-tetrahydroxy-7-methoxy-2-methyl-tetrahydroanthracen-9,10-dione and 8-(trihydroxy-7-methyl-2-methoxy-9,10-dioxo-anthracen-1-yl)-pentahydroxy-7-methoxy-2-methyl-tetrahydro-anthracen-9,10-dione, useful e.g. as antitumor agents

机译:新的乙酰氧基-四羟基-7-甲氧基-2-甲基-四氢蒽-9,10-二酮和8-(三羟基-7-甲基-2-甲氧基-9,10-二氧代蒽-1-基)-五羟基-7 -甲氧基-2-甲基-四氢蒽-9,10-二酮,例如有用作为抗肿瘤药

摘要

(1R,2S,3S,4R)-3-Acetoxy-1,2,4,5-tetrahydroxy-7-methoxy-2-methyl-1,2,3,4-tetrahydroanthracen-9,10-dione (I), and 8-(4,5,6-trihydroxy-7-methyl-2-methoxy-9,10-dioxo-9H,10H-anthracen-1-yl)-(1S,2S,3R,4S)-1,2,3,4,5-pentahydroxy-7-methoxy-2-methyl-1,2,3,4-tetrahydro-9H,10H-anthracen-9,10-dione (II), are new. Independent claims are included for: (1) the preparation of (I) or (II); and (2) the preparations of (I). ACTIVITY : Antibacterial; Fungicide; Virucide; Cytostatic. The antibacterial activity of (I) and (II) were tested in Streptococcus pneumoniaeusing in vitro assay. The results showed that the minimal inhibitory concentration of (I) and (II) was 7.8 mu g/ml. MECHANISM OF ACTION : None given.
机译:(1R,2S,3S,4R)-3-乙酰氧基-1,2,4,5-四羟基-7-甲氧基-2-甲基-1,2,3,4-四氢蒽-9,10-二酮(I) ,和8-(4,5,6-三羟基-7-甲基-2-甲氧基-9,10-二氧-9H,10H-蒽-1-基)-(1S,2S,3R,4S)-1, 2,3,4,5-五羟基-7-甲氧基-2-甲基-1,2,3,4-四氢-9H,10H-蒽-9,10-二酮(II)是新的。独立索赔包括:(1)(I)或(II)的制备; (2)(I)的制剂。活性:抗菌;杀菌剂杀病毒剂;止细胞的。使用体外测定法在肺炎链球菌中测试(I)和(II)的抗菌活性。结果表明,(I)和(II)的最小抑制浓度为7.8μg/ ml。作用机理:未给出。

著录项

  • 公开/公告号AT507298A4

    专利类型

  • 公开/公告日2010-04-15

    原文格式PDF

  • 申请/专利权人 SEALIFE PHARMA GMBH;

    申请/专利号AT20090000842

  • 发明设计人

    申请日2009-05-29

  • 分类号C07C50/18;A61K31/122;C07C46/10;

  • 国家 AT

  • 入库时间 2022-08-21 18:43:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号